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Abstract
Background: Given limited resources and time constraints, the use of existing systematic reviews (SR) for the
development of evidence-based public health recommendations has become increasingly important. Recently, a
five-step approach for identifying, analyzing, appraising and using existing SRs based on recent guidance by the US
Agency for Healthcare Research and Quality (AHRQ) was proposed within the Project on a Framework for Rating
Evidence in Public Health (PRECEPT). However, case studies are needed to test whether this approach is useful,
what challenges arise and how problems can be solved.
Methods: In two case studies, the five-step approach was applied to integrate existing SRs in the development of
evidence-based public health recommendations. Case study A focused on the role of neonatal sepsis as a risk factor
for adverse neurodevelopmental outcome. Case study B examined the efficacy, effectiveness and safety of influenza
vaccination during pregnancy. For each step, we report the approach of the review team, discuss challenges and
describe solutions.
Results: For case study A, one existing SR was identified, while in case study B four SRs were eligible for analysis.
We found that comparison of inclusion criteria alone was sufficient to judge on relevance of SRs in case study A,
but not B. Although methodological quality of all identified SRs was acceptable, risk of bias assessments of
individual studies included in the SRs had to be repeated in both case studies. Particular challenges appeared in
case study B where multiple SRs addressed the same research question. With the help of spreadsheets comparing
the characteristics of the existing SR we decided to use the most comprehensive one for our evidence synthesis
and supplemented the results with those from the other SRs.
Conclusions: In both case studies using the complete SR was not possible. The five-step approach provided useful
and structured guidance and should be routinely applied when using existing SRs as a basis for evidence-based
recommendations in public health. In situations where more than one SR has to be considered, the development
of spreadsheets comparing characteristics, inclusion criteria, risk of bias, included studies and outcomes seems
useful.
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Background
During recent years, the number of published systematic
reviews (SR) has increased nearly exponentially [1].
Therefore, scientists experience situations in which one
or more SRs for their guideline topic already exist, lead-
ing to the question whether and how these reviews can
be considered for guideline development. Moreover, lim-
ited resources and time constraints are important factors
leading to considerations on the use of existing SRs, in-
stead of performing new ones. This goes along with
questions regarding the methodological quality of the
existing reviews and their comprehensiveness, as well as
the potential need for updating. Accordingly, the issue of
using existing SRs for new reviews or guidelines has
raised a number of methodological concerns [2].
Current evidence assessment frameworks try to provide
guidance on how to integrate existing SRs into new
reviews. The Project on a Framework for Rating Evidence
in Public Health (PRECEPT), which has been initiated and
funded by the European Centre for Disease Prevention
and Control (ECDC), has developed methodological guid-
ance for evaluating and grading evidence in public health,
with a particular focus on infectious disease prevention
and control [3]. PRECEPT explicitly recommends the use
of existing SRs for evidence assessments, referring to the
five-step methodology developed by the US Agency for
Healthcare Research and Quality (AHRQ) and published
by Robinson et al. [4]. Recently, additional guidance for
this approach was published by the same group [5].
Case studies are needed to test whether this approach is
useful and to identify challenges and workable solutions
during the application process. Therefore, we used two
recent evidence assessment projects conducted in our
institute to test the applicability of the approach. These
projects were related to two domains of studies comprised
by PRECEPT, namely those on “risk factors” and “inter-
ventions.” In the first project, we aimed at assessing the
role of neonatal sepsis as a risk factor for adverse neurode-
velopmental outcome (case study A). This assessment was
part of a project on the burden of healthcare-associated
infections initiated and funded by ECDC. The second
project comprised an assessment of the efficacy, effective-
ness, and safety of influenza vaccination during pregnancy
(case study B) which has been performed to support the
decision-making process of the German Standing
Committee on Vaccination (STIKO).
Objectives
The objective of the study is to describe approaches,
challenges, and solutions regarding the use of existing
SRs for evidence assessments in infectious disease
prevention and control, using a comparative case study
that included two examples from different domains of
research (risk factors, interventions).
Methods
We performed a comparative case study on the use of
SRs for the development of new SRs. For both case stud-
ies, systematic searches and analyses were performed by
two teams of reviewers. For case study A (neonatal
sepsis), SH and TH performed the searches, analyzed
the data and finalized the SR, while TE acted as super-
visor. For case study B (influenza vaccination), CR and
TH performed the searches, analyzed the data, and final-
ized the SR, while OW acted as supervisor.
For the conduct of the SR of SRs, we used the
approach proposed by Robinson et al. which has been
incorporated in the PRECEPT framework [3]. This
approach comprises five steps which guide the user
through the process of identifying, analyzing, appraising,
and using existing SRs. In step 1, it is suggested to locate
the existing SRs, using a defined and reproducible
approach. In step 2, it is proposed to assess the
relevance of the identified existing reviews with regard
to the new review/evidence assessment, by comparing
the inclusion criteria to those of the new SR. In step 3,
the assessment of the methodological quality of the
identified SR(s) is suggested. Step 4 proposes four differ-
ent but not mutually exclusive approaches to determine
appropriate use and incorporation of existing SRs into
new reviews. This includes
(i) using the included studies as a quality check for an
own literature search
(ii)using the existing review to provide the body of
included studies
(iii)using the data abstraction, risk of bias assessment,
and/or analyses from existing SRs
(iv) using the complete existing review
Step 5 suggests to report methods and results from
existing SRs. The complete approach is illustrated in
Fig. 1.
For each of the five steps of the approach, details on
procedures performed for case studies A and B were
documented. We considered challenges arising from the
application of the approach for each step separately and
how they were handled. Finally, a table was constructed
that compares the major challenges experienced between
both case studies A and B.
Results
Case study A: neurological sequelae of healthcare-
associated sepsis in very-low-birth weight infants
Background
Sepsis is suspected to be a frequent cause of neurological
impairment in very low birth weight (VLBW) infants.
However, the risk of sequelae attributable to sepsis,
particularly in the context of healthcare-associated
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infections, is not known. Therefore, we aimed at system-
atically assessing the published evidence on neurological
sequelae of healthcare-associated sepsis by using existing
SRs. The respective paper reporting the results of this
evidence assessment has been published recently [6].
Step 1: locate existing systematic reviews
Approach
To identify SRs on neurological sequelae of healthcare-
associated sepsis in VLBW infants, we performed a sys-
tematic literature search in MEDLINE, EMBASE, and
the Cochrane library. The search was limited to SRs
published after 1 January 2000. We applied a modifica-
tion of the health-evidence.ca search filter [7] which
included the following terms: “Medline” OR “systematic
review” OR “meta-analysis” OR “intervention.” The
search led to the identification of 207 entries. After
screening of titles, abstracts, and full publications, one
potentially relevant SR remained for analysis (Alshaik
et al. 2013 [8]) (see Appendix 1 and Additional file 1:
Figure S1 for details).
Challenges and solutions
 To ensure that all existing SRs were identified by a
transparent and reproducible approach, a systematic
search was performed. A particular challenge was to
develop a search strategy which was not only highly
sensitive but showed a sufficient specificity to
separate SRs from original studies. Therefore, we
decided to apply specific search filters to narrow the
results of the search.
 Although the application of search filters provided
an acceptable (and plausible) number of entries, it
was necessary to read the full texts from a large
number of publications to decide on eligibility. In
particular, even from the abstract, it was not always
possible to decide whether the respective
publication was a SR. Therefore, in some cases, the
full text had to be assessed.
Step 2: assess relevance of identified systematic reviews
Approach
To assess the relevance of the identified SR [8], we com-
pared its inclusion criteria to a priori defined inclusion
criteria of our new review. As suggested in PRECEPT,
we used the PI(E)CO (population, intervention (expos-
ure), comparison, outcome) format [3]. As shown in
Table 1, this comparison revealed that differences
regarding PICO were rather small. In general, the review
by Alshaik et al. was more restrictive in each of the
PICO criteria, with the exception of the comparator
which was not explicitly defined by the authors but
implicitly the same as in our review.






Determine appropriate useStep 4
Report methods and results Step 5
Fig. 1 Methodological steps for identifying, assessing, and applying
existing systematic reviews. Footnote: Step 4 comprises the
following options: (i) using the included studies as a quality check
for literature search, (ii) using the existing review to provide the
body of included studies, (iii) using the data abstraction, risk of bias
assessment, and/or analyses from existing systematic reviews,
(iv) using the complete existing review
Table 1 Case study A: comparison of PI(E)CO (population,
intervention (exposure), comparator, outcome) criteria between
the identified systematic review (Alashaik et al. [8]) and our own
new review (Haller et al. [6])
Alshaik et al. [8] Own new review
(Haller et al. [6])
Population Very low birth weight
(VLBW) infants
Neonates (no restrictions
regarding birth weight or
gestational age)
Exposure Culture-proven sepsis Sepsis
Comparator Not explicitly mentioned No sepsis
Outcome Moderate to severe neuro
developmental impairment,
including at least one of the
following: cerebral palsy,
cognitive delay (cognitive
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Challenges and solutions
 Compared to our predefined criteria, Alshaik et al.
did not make any restrictions regarding study design
of the included studies, although focused on cohort
and case–control studies. Since we aimed at
calculating risk differences in our SR, we had to
limit our search to cohort studies. Therefore, we
had to exclude three case–control studies and a
further three studies since they did not report
appropriate data for calculation of risk differences.
In addition, one study did not report relevant
outcomes and was therefore excluded.
 Among the 17 studies identified and reported to be
eligible by Alshaik et al., there was one study that
we were not able to retrieve in databases or via the
Internet. After internal discussions, we decided to
report this finding in the publication and proceed
with the remaining studies.
Step 3: assess quality of existing systematic reviews
Approach
As suggested in the guidance paper [4], we applied a
commonly used tool to assess the quality of the existing
SR, namely, the Assessment of Multiple Systematic Re-
views (AMSTAR) tool [9]. Two independent observers
assessed the quality of the SR by Alshaik et al. [8]. Four
of the 11 domains of AMSTAR were found to be not ad-
equately addressed in this SR: A list of excluded publica-
tions was not provided, no risk of bias assessment was
performed and could not be used for formulating
conclusions, and conflict of interest in the included
studies was not investigated. Both independent re-
searchers agreed on an AMSTAR summary score of
7/11 (Table 2).
Challenges and solutions
 Since a threshold for an AMSTAR score indicating
“high methodological quality” has not been defined
so far, uncertainties remain how to judge the results
of the AMSTAR assessment. We chose to use a
rather conservative approach and judged the review
being of “acceptable methodological quality.”
However, it remains uncertain at which AMSTAR
score “threshold” researchers should refuse the use
of an existing SR due to low methodological quality.
 One major AMSTAR domain that led to
downgrading of the AMSTAR score was the lack of
a risk of bias assessment of the included studies in
the review by Alshaik et al. However, we considered
this issue of minor importance since we performed
our own risk of bias assessment for the new review
(see below).
Step 4: determine appropriate use and incorporate
existing systematic reviews
Approach
Since we aimed at calculating attributable risk for each
study, it was necessary to re-analyze the cohort studies
included in the SR by Alshaik et al., corresponding to
option (ii) in the paper by Robinson et al. [4] (see above).
We performed data extraction using standardized data
extraction sheets and assessed risk of bias of the original
cohort studies.
Challenges and solutions
 In contrast to using the analysis of the existing
review, re-analysis of the entire body of evidence
requires much more resources. However, for our
purposes, a re-analysis was necessary. At this point,
the approach does not differ from the procedures
used in a conventional SR regarding data extraction,
checking, and data synthesis.
 We used the Newcastle Ottawa Scale to perform risk
of bias assessment of all original studies included in
that review [10]. Like data extraction, risk of bias
assessment was performed by two independent
investigators. Of the nine included studies, three had
a high risk of bias, while the remaining six had a low
risk of bias (for details, see [6]).
Step 5: report methods and results from existing
systematic reviews
Approach
Since we extracted and re-analyzed data of original
studies, reporting of methods and results did not dif-
fer from the approaches used when a new SR is per-
formed. In the respective publication, we used a table
to report location of the study, birth year, population
characteristics, definition of sepsis, and duration of
follow-up for each included study, along with the re-
sults of the risk of bias assessment. This was accom-
panied by forest plots showing the risk differences
from the individual studies and the pooled estimate
for each outcome (cerebral palsy, vision impairment,
hearing impairment, impaired neurodevelopment) (see
Haller et al. [6] for details).
Challenges and solutions
 The approach used to report the results of the
assessment was very similar to a conventional SR
implicating that much more time and resources
were needed, compared to a situation when data
extraction and analysis from the existing SR could
be used. However, using the existing results of the
literature search still appears to be a time- and
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resource-saving strategy, compared to performing a
new review.
 We decided to consider the original primary studies
rather than the information reported in the SR as
data source to avoid perpetuation of possible
extraction errors.
Case study B: efficacy, effectiveness and safety of
influenza vaccination during pregnancy
Background
Influenza vaccination during pregnancy is recommended
by the World Health Organization and many national
health authorities to ensure protection to the pregnant
woman and her newborn against influenza and associ-
ated complications [11, 12]. However, immunization
during pregnancy warrants particular attention regarding
adverse events. We aimed at systematically assessing the
published evidence on efficacy/effectiveness and safety
of vaccination against influenza during pregnancy, using
existing SRs.
Step 1: locate existing systematic reviews
Approach
To identify eligible SRs, we performed a systematic lit-
erature search in MEDLINE, in EMBASE, and in the
Cochrane Database of Systematic Reviews. The initial
search identified a total of 45 entries. After screening of
titles, abstracts, and full texts, four potentially relevant
SRs remained. All of them reported syntheses of data on
either efficacy/effectiveness or safety of influenza
vaccination during pregnancy, or both [13–16] (see
Appendix 1 and Additional file 1: Figure S1 for details).
Challenges and solutions
 Since pregnant women are a part of the healthy adult
population, we expected to find relevant information
also as part of SRs on influenza vaccination in healthy
adults. Therefore, we extended our search which,
however, reduced specificity of the search strategy. In
fact, one of the identified SRs (Jefferson et al. [15])
was a Cochrane review on vaccines for preventing
influenza in healthy adults which contained a separate
chapter on pregnant women and their newborns.
Thereby, our case study supports the idea that some
topics necessitate broadening the search to capture all
relevant systematic reviews. In fact, a search limited
to pregnant women only would not have identified
the Cochrane review.
Step 2: assess relevance of identified systematic reviews
Approach
As in case study A, we started to assess the relevance of
the identified SRs by comparing their inclusion criteria
to those of our own review, using the PICO format.
Generally, comparison of PICOs revealed only small dif-
ferences between the existing SRs, with one notable ex-
ception (Table 3). The SR by Fell et al. [13] focused on
preterm birth and fetal death but did neither investigate
maternal outcomes nor those related to the efficacy or
Table 2 Case studies A and B: comparison of AMSTAR (Assessment of Multiple Systematic Reviews) tool domain ratings in the
identified systematic reviews
AMSTAR domainsa Alshaik et al. [8] Galvao et al. [14] Jefferson et al. [15] Fell et al. [13] McMillan et al. [16]
Was an “a priori” design provided? Yes Yes Yes Yes Yes
Was there duplicate study selection and data extraction? Yes Yes Yes Yes Yes
Was a comprehensive literature search performed? Yes Yes Yes Yes Yes
Was the status of publication used as an inclusion
criterion?
Yes Yes Yes No No
Was a list of studies (include and excluded) provided? No Yes Yes Yes Yes
Were the characteristics of the included studies
provided?
Yes Yes Yes Yes Yes
Was the scientific quality of the included studies assessed
and documented?
No Yes Yes Yes Yes
Was the scientific quality of the included studies used
appropriately in formulating conclusions?
No Yes Yes Yes Yes
Were the methods used to combine the findings of
studies appropriate?
Yes Yes Yes Yes Yes
Was the likelihood of publication bias assessed? Yes Yes Yes Yes No
Was the conflict of interest included? No No Yes No Yes
Summary scoreb 7 10 11 9 9
aAccording to Shea et al. [9]
bMaximum score: 11 (yes = 1 point)
Harder et al. Systematic Reviews  (2016) 5:171 Page 5 of 13
effectiveness of vaccination in preventing influenza in
the infant.
Challenges and solutions
 A more detailed analysis revealed that the
comparison of PICOs alone would not suffice to
assess the relevance of the identified SRs. In
particular, by screening the SRs, we detected
considerable differences regarding study designs of
the included studies, numbers of included studies,
inclusion of pandemic and/or seasonal influenza
vaccines, etc. Therefore, we decided to construct an
additional spreadsheet for comparison of
characteristics of the SRs (Table 4). These
comparisons revealed differences with regard to the
study designs of the included studies defined
a-priori. While the Cochrane review [15] and the SR
by McMillan et al. [16] did not make any restrictions
regarding the design of the studies to be included,
Galvao et al. [14] decided to include only RCTs and
cohort studies, whereas Fell et al. [13] in addition
included cross-sectional and case–control studies.
Three of the SRs included studies concerning
seasonal as well as pandemic influenza vaccines,
while the remaining SR (Galvao et al. [14]) focused
on vaccination against seasonal influenza only. In
three SRs, a meta-analysis was performed.
Remarkably, considerable differences between the
SRs were observed with regard to the number of
included studies which ranged between 8 and 46.
 Furthermore, the identified SRs differed considerably
regarding included maternal and infant outcomes.
To assess these differences in detail, we constructed
a further table comparing the included outcomes
with respect to the original studies where they were
Table 3 Case study B: comparison of PICO (population, intervention, comparator, outcome) criteria between the existing systematic
reviews (Galvao et al. [14], Jefferson et al. [15], Fell et al. [13], and McMillan et al. [16]) and our own new review
Galvao et al. [14] Jefferson et al. [15] Fell et al. [13] McMillan et al. [16] Own new review
Population Pregnant women
and their infants




Pregnant women, their fetuses and









Inactivated influenza vaccination Vaccination against
seasonal influenza
Comparator Placebo or other
vaccines or no
vaccination













Influenza, influenza-like illness, for
pregnant women: adverse events
and serious adverse events; for the
fetus: spontaneous abortion, fetal
death, premature birth, low birth






in mother or infant
Table 4 Case study B: comparison of additional characteristics between the existing systematic reviews (Galvao et al. [14], Jefferson
et al. [15], Fell et al. [13], and McMillan et al. [16]) and our own new review
Galvao et al. [14] Jefferson et al. [15] Fell et al. [13] McMillan et al. [16] Own new review
Study designs RCTs, cohort studies All study designs RCTs, cohort, cross-sectional,
case–control studies
All study designs All study designs
Period covered Until 09/2013 Until 05/2013 Until 05/2013 Until 03/2014 Until 03/2014
Seasonal Yes Yes Yes Yes Yes
Pandemic No Yes Yes Yes No
Meta-analysis No Yes Yes Yes No
No. of included studies 8 21 27 46 20






NA JBI-MASTARI Cochrane risk
of bias tool
Risk of bias tool(s) used
for observational studies
NR NOS NOS; DBC JBI-MASTARI CASP
Results of risk of bias
assessment
NR 10× high risk of bias;
11× unclear risk of bias
NOS: median 8.5 (of 9)
DBC: median 25 (of 31)
Moderate to high
quality
9× high risk of bias;
9× low risk of bias;
2× unclear risk of bias
CASP Critical Appraisal Skills Program, DBC Downs and Black Checklist, NA not applicable, NOS Newcastle-Ottawa-Scale, NR not reported
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reported (Table 5). This comparison revealed that a
total of 14 outcomes were reported in the four
systematic reviews. The most comprehensive data
base was provided by the SR by McMillan et al. [16],
while the SR by Fell et al. [13], due to its inclusion
criteria, reported the smallest number of outcomes.
Step 3: assess methodological quality of existing
systematic reviews
Approach
As shown in Table 2, all four potentially relevant reviews
received high AMSTAR summary scores, ranging
between 9/11 and 11/11 points. Therefore, we concluded
that regarding methodological quality, the SRs were
nearly equal. Differences were observed regarding single
domains: Two SRs did not consider “status of publica-
tion” adequately, one did not investigate publication
bias, and only two SRs considered conflict of interest in
the included studies.
Challenges and solutions
 As discussed in case study A, it is unclear what
“high methodological quality” means in terms of the
AMSTAR summary scores. Furthermore, empirical
studies are missing which investigate whether or not
a SR with an AMSTAR summary score of 11 is
superior to one with an AMSTAR score of 9. Rather,
it appears to be important to consider the domains
in which differences were observed. We judged all
four SRs as being of adequate methodological
quality.
Step 4: determine appropriate use and incorporate
existing systematic reviews
Approach
Since in step 2 we had identified the SR by McMillan
et al. [16] as the most comprehensive one, we decided to
use this SR as the base for our evidence synthesis. In
those cases where single studies or outcomes were miss-
ing from the review by McMillan et al., we supple-
mented the results with those from the other SR, using
the spreadsheet shown in Table 5 as guidance.
Challenges and solutions
 As show in Table 4, we observed that in the four
SRs a total of four different risk of bias tools were
applied to assess internal validity of RCTs and
observational studies. We therefore decided to
re-analyze risk of bias in the primary original
studies, using the Cochrane risk of bias tool for
randomized controlled trials [17] and the Newcastle
Ottawa Scale for cohort studies [10]. Like data
extraction, risk of bias assessment was performed by
two independent investigators (for results, see
Table 4).
Step 5: report methods and results from existing
systematic reviews
Approach
Using the approach described above, we performed a
new evidence synthesis for all outcomes reported in the
20 original studies contributing to the four SRs. We
aggregated the study estimates in tables, separately for
RCTs and observational studies.
Challenges and solutions
 Data from the original studies were very
heterogeneous regarding study populations, vaccines
used, and outcome definitions. Therefore, although
meta-analyses were performed in three of the SRs, we
decided not to perform a quantitative data synthesis
but to report the non-aggregated study results in
tables.
Comparison of major challenges in case studies A and B
In Table 6, we summarized the major challenges and
solutions along steps 1 to 5 for both case studies. Obvi-
ously, the challenges and respective solutions at each of
the five steps differed between the two case studies. Only
in step 3 (assessing quality), similar challenges occurred
with regard to the interpretation of the AMSTAR score.
Many challenges in case study A were related to the
need of performing a completely new data extraction
and analysis. In case study B, the majority of challenges
was caused by partial overlap of the studies included in
the different SRs and the resulting question how to deal
with this situation.
Discussion
Major aim of our work described here was to test the
application of the AHQR approach in the context of
using systematic reviews for developing evidence-based
recommendations in the field of infectious disease pre-
vention and control. Importantly, this might also include
research questions which do not come from the field of
comparative effectiveness but include topics like risk
factors or incidence. Nevertheless, we conclude that the
approach is applicable to these scenarios and provides
excellent guidance for the use of systematic reviews also
in this context.
The use of existing SRs for the development of new
SRs has been suggested to be an efficient way to develop
evidence-based recommendations in public health, offer-
ing a time- and resource-saving alternative to the
conduct of a new SR. Our comparative case study shows
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Table 5 Case study B: comparison of included primary studies and outcomes in the existing systematic reviews (Galvao et al. [14],
Jefferson et al. [15], Fell et al. [13], and McMillan et al. [16])
Maternal outcomes
Outcome Primary study Galvao et al. [14] Jefferson et al. [15] Fell et al. [13] McMillan et al. [16]
Laboratory-confirmed influenza Thompson et al. [30] No (unclear) No (date) No (criteria) Yes
Zaman et al. [31] No (unclear) No (unclear) No (criteria) Yes
Influenza-like illness Black et al. [32] No (unclear) Yes No (criteria) Yes
Hulka [33] Yes Yes No (criteria) No (unclear)
Munoz et al. [34] No (unclear) No (unclear) No (criteria) Yes
Zaman et al. [31] Yes No (unclear) No (criteria) No (unclear)
Local adverse events Hulka [33] No (criteria) No (unclear) No (criteria) Yes
Yeager et al. [35] No (criteria) No (unclear) No (criteria) Yes
Zaman et al. [31] No (criteria) No (unclear) No (criteria) Yes
Systemic adverse events Englund et al. [36] No (criteria) No (unclear) No (criteria) Yes
Hulka [33] No (criteria) No (unclear) No (criteria) Yes
Lin et al. [37] No (criteria) No (unclear) No (criteria) Yes
Yeager et al. [35] No (criteria) No (unclear) No (criteria) Yes
Zaman et al. [31] No (criteria) No (unclear) No (criteria) Yes
Serious adverse events Munoz et al. [34] No (criteria) No (unclear) No (criteria) Yes
Nordin et al. [38] No (criteria) Yes No (criteria) Yes
Preeclampsia Munoz et al. [34] No (criteria) No (unclear) No (criteria) Yes
Infant outcomes
Lab-confirmed influenza Benowitz et al. [39] No (criteria) Yes No (criteria) Yes
Eick et al. [40] Yes Yes No (criteria) Yes
Poeling et al. [41] No (criteria) Yes No (criteria) Yes
Zaman et al. [31] Yes No (unclear) No (criteria) Yes
Influenza-like illness Black et al. [32] No (unclear) Yes No (criteria) Yes
Eick et al. [40] No (unclear) Yes No (criteria) Yes
France et al. [42] No (unclear) Yes No (criteria) No (unclear)
Munoz et al. [34] No (unclear) No (unclear) No (criteria) Yes
Zaman et al. [31] Yes No (unclear) No (criteria) Yes
Premature birth (<37 weeks) Black et al. [32] Yes Yes Yes Yes
Chambers et al. [43] No (unclear) No (date) Yes Yes
Dodds et al. [44] No (unclear) No (unclear) Yes No (unclear)
Legge et al. [45] No (date) No (date) Yes No (unclear)
Louik et al. [46] No (date) No (unclear) Yes No (unclear)
Munoz et al. [34] Yes Yes Yes Yes
Omer et al. [47] Yes Yes Yes Yes
Sheffield et al. [48] Yes Yes Yes Yes
Steinhoff et al. [49] No (unclear) No (unclear) Yes No (unclear)
Zaman et al. [31] Yes No (unclear) No (unclear) No (unclear)
Fetal death (>500 g) Sheffield et al. [48] Yes Yes Yes Yes
Spontaneous abortion Irving et al. [50] No (criteria) No (date) No (criteria) Yes
Congenital malformation Munoz et al. [34] No (criteria) Yes No (criteria) No (unclear)
Sheffield et al. [48] No (criteria) Yes No (criteria) Yes
Small for gestational age Omer et al. [47] Yes No (unclear) No (criteria) Yes
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that applying the five-step approach by Robinson et al. [4]
which is integrated in the PRECEPT evidence assessment
framework [3] leads to a transparent evidence assessment
based on existing SRs. However, depending on the quan-
tity and quality of existing SRs for the given research ques-
tion, different challenges have to be managed during the
evidence assessment process. Furthermore, we experi-
enced that in cases when extensive re-analysis was needed
because the existing SRs did not report appropriate data
from the primary studies, the advantages of using existing
SRs over performing a new SR are likely to be small.
In our experience in conducting systematic reviews
“from scratch,” 1/3 of time has to be spent for literature
search, 1/3 for data extraction, and 1/3 for data analysis
and interpretation of the data, respectively. We think
that it is worth using existing reviews, if at least one of
these three “steps” can be omitted. We estimated that a
full systematic review takes six to 24 months, depending
on complexity of question, number of relevant out-
comes, relevant publication dates, etc. In our experience,
by using existing systematic reviews instead of starting a
new one, this process can be shortened by about one to
two thirds, depending on topic, comprehensiveness, and
quality of the existing reviews.
Overviews of SR are a new approach of evidence synthe-
sis which becomes increasingly popular [18]. However, it
has been recognized earlier that a number of methodo-
logical challenges exist related to these approaches [19].
So-called umbrella reviews can be considered to be a spe-
cific form of SRs of SRs by focusing on meta-synthesis of
the results of comparable meta-analyses [20]. However,
our case study illustrates that it might be of equal import-
ance to develop methodological guidance for those cases
where detailed comparison and dissection of the existing
SRs rather than synthesis are needed. For the development
of the PRECEPT framework, we decided to use the
approach proposed by Robinson et al. [4] which has
recently been further elaborated by the same group [5].
Our case studies A and B showed large differences
regarding the evidence base. While case study A had to
build on only one SR, for case study B four SRs were
identified. At first look, these SRs appeared very similar
regarding methodological quality and thematic rele-
vance. However, further analysis revealed several
challenges resulting from differences, e.g., in included
studies, considered outcomes and risk of bias assess-
ments. All reviews included in both case studies had
very broad PICO questions, particularly with regard to
the outcomes. The systematic reviews on influenza vac-
cination during pregnancy for example did not focus on
one or two outcomes, but used groups of outcomes such
as “adverse events during pregnancy” which were
Table 5 Case study B: comparison of included primary studies and outcomes in the existing systematic reviews (Galvao et al. [14],
Jefferson et al. [15], Fell et al. [13], and McMillan et al. [16]) (Continued)
Sheffield et al. [48] Yes No (unclear) No (criteria) Yes
Zaman et al. [31] Yes No (unclear) No (criteria) No (unclear)
Neonatal death Sheffield et al. [48] Yes Yes No (criteria) No (unclear)
No, no included (with reasons for exclusion in parenthesis: date = published after search date of the SR; criteria = inclusion criteria of the SR not met;
unclear = reason for exclusion from the SR unclear); Yes, included
Table 6 Comparison of steps 1–5: major challenges and solutions in case studies A and B
Step
number
Description Case study A: neurological sequelae of neonatal sepsis Case study B: influenza vaccination during pregnancy
Challenges Solutions Challenges Solutions
1 Locate existing
systematic reviews
Need to restrict search
results to SRs
Use of search filters Relevant SRs can be
part of overarching SRs
Widening of the search
strategy to more unspecific
topics (e.g., “healthy adults”)
2 Assess relevance of
the existing reviews
Non-retrievable
references in relevant SR
Reporting of this finding in
the new SR




characteristics of SRs and
included individual studies
3 Assess quality of
existing reviews
Value of AMSTAR summary
score not known
AMSTAR summary score of











Numbers and risk of bias not
reported in SR
New data extraction from
individual studies and risk
of bias assessment
Different risk of bias
tools used in the
relevant SRs
New risk of bias assessment
with a defined tool






Summary of data from
the individual studies





results of individual studies
in tables, no meta-analysis
SR systematic review
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presented in an aggregated as well as non-aggregated
way. Comparing the systematic reviews on influenza vac-
cination during pregnancy we realized that the authors
transformed the data differently, e.g., regarding out-
comes such as “fetal death,” “stillbirth,” “abortion,” or
“intrauterine death.”
Interestingly, already 20 years ago, Jadad et al. dis-
cussed problems which might arise when SRs on the
same topic come to discordant results or conclusions
[21]. In our study, one particular challenge arose from
the fact that the four SRs had partially overlapping stud-
ies. A recent study by Siontis et al. suggested that this
problem is not uncommon. Of 73 meta-analyses ana-
lyzed in their article, 67 % had at least one other over-
lapping meta-analysis [22]. Siontis et al. proposed three
possible solutions for such a scenario: (i) to select the
most appropriate SR, (ii) to perform a new review, or
(iii) to synthesize the results of the reviews. Similar chal-
lenges in analyzing and using existing SRs with overlap-
ping topics have been recently described by Bolland and
Grey [23]. Like in our study, these authors observed im-
portant differences in trial selection between seven
meta-analyses on vitamin D supplements. Other re-
searchers have developed graphical tools to assist in the
assessment of appropriateness of each meta-analysis for
a given research question [24]. In our study, we decided
to apply the concept of comparative spreadsheets sug-
gested by Whitlock et al. [2] to compare certain features
of the included systematic reviews to assess their value
for a new evidence synthesis. We thereby identified the
most comprehensive review [16] and supplemented this
study base with the results of the other three SRs. How-
ever, it has to be considered that our approach of select-
ing the most comprehensive review and supplementing
it with studies identified in other reviews does not al-
ways work. The most comprehensive review may not be
of the highest quality, it ignores the possibility that the
selection criteria of the review authors were not entirely
transparent, it does not eliminate the need for risk of
bias assessment, and it still might require evidence as-
sessments to be done. Furthermore, AMSTAR does not
completely separate assessment of bias from reporting
quality. It has to be investigated whether the recently de-
veloped ROBIS tool [25] performs better in capturing
risk of bias in systematic reviews.
In step 4 of the approach, it is suggested to either use
the results of the risk of bias assessments from the exist-
ing SRs for the new review or to perform a new assess-
ment. In case study A, the latter approach was
ultimately necessary since the existing review did not re-
port risk of bias in the included studies. On the contrary,
in case study B, all included SRs reported their own risk
of bias assessments. However, these were based on four
different risk of bias tools. In all SRs, assessments of
RCTs were performed by using the Cochrane risk of bias
tool [17], whereas for observational studies either the
Newcastle Ottawa Scale [10], the Downs and Black
Checklist [26], or the JBI-MASTARI tool [16] was used.
The authors of these SRs came to differing conclusions
regarding the methodological quality of the included ori-
ginal studies. Although a comparison of risk of bias as-
sessments between the reviews would be interesting,
reporting quality of these results showed large differ-
ences, making a direct comparison impossible: The sys-
tematic review by Fell et al. reported numerical quality
scores per study, but not per outcome, using the New-
castle Ottawa Scale and the Downs-Black Scale. In the
Methods section of the review by Galvao et al., it was
declared that the Cochrane risk of bias tool was used,
but the authors did not report the results of this assess-
ment. In the systematic review by McMillan et al., the
JBI-MASTARI was used, but the results of this assess-
ment were reported in aggregated form only, rather than
for individual studies and outcomes. However, one has
to take into account that even the use of identical risk of
bias tools can lead to different judgements on methodo-
logical quality by different authors, since it has been
demonstrated that many risk of bias tools show a con-
siderable degree of inter-rater variability [10, 27]. Taking
all these uncertainties into account, we decided to per-
form a new risk of bias assessment for our review, and
compared the results to those by the other investigators.
Remarkably, quality of the evidence was not assessed
in the original systematic review by Alshaik et al. which
served as the base for our case study A. Regarding the
systematic reviews used in case study B, only one
(Galvao et al.) of four reviews reported a GRADE quality
assessment. However, due to differences in the number
of included studies, it is difficult to compare the results
of the assessment made by those authors to our GRADE
assessments. Furthermore, updating of existing system-
atic review constitutes an important step which should
be considered in every situation when the use of existing
reviews is discussed as an approach in the development
of evidence assessments. Importantly, methods have
been developed to evaluate the need for updating, such
as the surveillance system proposed by AHRQ [28].
Conclusions
Our comparative case study supports the applicability of
the five-step approach [4] included in the PRECEPT
framework for the use of existing SRs. However, efforts
and challenges depend on the quality and quantity of the
evidence in the SRs. Exclusion of non-systematic (or
narrative) reviews constitutes a particular challenge since
they can often not been identified without reading the
full text of the respective article. Important progress in
literature searches could be made if this kind of reviews
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would be adequately termed and indexed in electronic
databases. Adherences of all SR authors to the PRISMA
guideline [29] would strongly improve the quality of
published reviews. Authors of systematic reviews should
provide a database (e.g., an Endnote file) alongside with
the paper to support replication, re-analysis, and updat-
ing of the respective systematic reviews. In situations
where more than one SR has to be considered, the
development of spreadsheets comparing characteristics,
inclusion criteria, risk of bias, included studies, and out-
comes can support the development of evidence-based
guidance. For such situations, we used our experiences
documented in this paper to develop a recommendation
on how to proceed (Table 7). Furthermore, our study
identified a number of open questions which should be
addressed in future studies, such as
 What is a “good” AMSTAR score?
 How to deal with overlapping studies when using
existing systematic reviews?
 When is it more efficient to perform a new
systematic review (in terms of time and resources)
than to try to use an existing one?
The use of a complete SR is often not possible and
intensive re-analyses are necessary. Still, even when such
reanalyses are needed, the use of existing SRs is a prom-
ising alternative to the conduct of a new SR and might
support fast and efficient development of evidence-based
recommendations in public health.
Appendix
Appendix 1
Search strategy for case study A (Databases searched:
MEDLINE, EMBASE, and the Cochrane Central Register
















#16 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR
#8 OR #9 OR #10 OR #11 OR #12) AND (#13 OR
#14) AND #15
Filters: publication date from 2000/01/01; humans;
“Medline” OR “systematic review” OR “meta-analysis”
OR “intervention”
Search strategy for case study B. (Databases searched:
MEDLINE, EMBASE and the Cochrane Database of








#8 (#1 OR #2)
#9 (#4 OR #5)
#10 (#6 OR #7)
#11 3 AND 8 AND 9 AND 10
Filters: −
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Additional file 1: Case study A: flow chart for the systematic literature
search and study selection. (DOCX 87 kb)
Abbreviations
AHRQ: Agency for Healthcare Research and Quality; AMSTAR: Assessment of
Multiple Systematic Reviews; PRECEPT: Project on a Framework for Rating




This work was performed as a pilot of the Project on a Framework for rating
Evidence in Public Health (PRECEPT). PRECEPT is funded by the European
Centre for Disease Prevention and Control (ECDC; tenders no. 2012/040;
2014/008). The systematic review on neurological sequelae of neonatal
sepsis was conducted within the project “Evidence-based research to
develop outcome trees for healthcare-associated infections” funded by the
European Centre for Disease Prevention and Control (contract no. 4226).
Availability of supporting data
Not applicable.
Table 7 Recommendation: how to proceed with overlapping
systematic reviews on the same topic
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8) Perform meta-analysis, if useful and needed
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